Preventive vaccination of tuberculosis for children in Russia and other countries
https://doi.org/10.34215/1609-1175-2021-2-75-79
Abstract
The analysis of international data on a policy of specific preventive tuberculosis immunization among children in modern conditions was conducted. The data on Russian Federation for the recent years taking into account children disease indexes is presented. The vaccination data in Moscow taking into account medical and nonmedical exemptions was analyzed. There is a conclusion about increasing vaccination rate against tuberculosis in maternity hospitals and polyclinics.
About the Authors
T. A. SevostyanovaRussian Federation
MD, PhD, deputy head of the Children’s Department
3 Barbolina St., Moscow, 107014, Russian Federation
V. A. Aksenova
Russian Federation
MD, PhD, professor, head of the Child and Adolescent Department
4 Dostoevsky St., Moscow, 1274736 Russian Federation
E. M. Belilovsky
Russian Federation
PhD, head of the Department of Epidemiological Monitoring of Tuberculosis
3 Barbolina St., Moscow, 107014, Russian Federation
References
1. Netea MG, van Crevel R. BCG-induced protection: effects on innate immune memory. Semin Immunol. 2014; 26:512–7.
2. Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LAB, Jacobs C, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun. 2014;6(2):152–8.
3. Levy DT, Alexandrova NV. Vaccine prophylaxis of tuberculosis. Biopreparations. 2015;2:4–8 (In Russ).
4. World Health Statistics 2017: Monitoring health for the SDGs, sustainable development Goals. URL: http://www.who.int/immunization/programmes_systems/procurement/v3p/platform/en (Accessed 10 November 2020).
5. The SAGE meeting of 17–19 October 2017 was held in the Executive Board (EB) room at WHO HQ in Geneva. URL: http://www.who.int/immunization/sage/meetings/2017/october/presentations_background_docs/en (Accessed 23 November 2020).
6. WHO/UNICEF joint reporting process. Data, statistics and graphics 2016. URL: http://www.who.int/immunization/monitoringsurveillance/data/en (Accessed 10 November 2020).
7. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Nelson LJ, et al. The clinical epidemiology of childhood pulmonary tuberculosis: A critical review of literature from the pre-chemotherapy era. Int J Tuberc. Lung Dis. 2004;8(3):278–85.
8. Aksenova VA. Forecast of the epidemic situation of tuberculosis in children in the Russian Federation. BCG vaccination: what will happen tomorrow. BCG Vaccine: 85 years later: scientific and practical materials. symposium. Saint Peterburg; 2010:11–6 (in Russ).
9. Report on BCG vaccine use for protection against mycobacterial infections including tuberculosis, leprosy, and other nontuberculous mycobacteria (NTM) infections. Prepared by the SAGE Working Group on BCG Vaccines and WHO Secretariat 22. September 2017. URL: https://www.who.int/immunization/sage/meetings/2017/october/1_BCG_report_revised_version_online.pdf?ua=1 (Accessed 15 April 2020).
10. Summary of Key Points WHO Position Paper on BCG Vaccine, February 2018. URL: https://www.who.int/immunization/policy/position_papers/PP_BCG_Presentation_2018.pdf (Accessed 26 April 2020).
11. WHO. Evidence to recommendation table: Need for revaccination.URL: www.who.int/entity/immunization/policy/position_papers/bcg_evidence_recommendation_table_revaccination.pdf (Accessed 26 April 2020).
12. Bogorodskaya EM, Litvinov VI, eds. Antitubercular work in the city of Moscow: An analytical review of statistical indicators on tuberculosis. Moscow: MSPCTC; 2019 (in Russ).
Review
For citations:
Sevostyanova T.A., Aksenova V.A., Belilovsky E.M. Preventive vaccination of tuberculosis for children in Russia and other countries. Pacific Medical Journal. 2021;(2):75-79. (In Russ.) https://doi.org/10.34215/1609-1175-2021-2-75-79